Peclat, T. R., Shi, B., Varga, J., & Chini, E. N. (2020). The NADase enzyme CD38: An emerging pharmacological target for Systemic Sclerosis, Systemic Lupus Erythematosus and Rheumatoid Arthritis. Curr Opin Rheumatol.
Stile di citazione ChicagoPeclat, Thais Ribeiro, Bo Shi, John Varga, e Eduardo Nunes Chini. "The NADase Enzyme CD38: An Emerging Pharmacological Target for Systemic Sclerosis, Systemic Lupus Erythematosus and Rheumatoid Arthritis." Curr Opin Rheumatol 2020.
Citazione MLAPeclat, Thais Ribeiro, Bo Shi, John Varga, e Eduardo Nunes Chini. "The NADase Enzyme CD38: An Emerging Pharmacological Target for Systemic Sclerosis, Systemic Lupus Erythematosus and Rheumatoid Arthritis." Curr Opin Rheumatol 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.